These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23763498)
1. An experimental and theoretical investigation of loperamide hydrochloride-glutaric acid cocrystals. Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Freccero M; Scotti F; Milanese C; Girella A; Marini A J Phys Chem B; 2013 Jul; 117(27):8113-21. PubMed ID: 23763498 [TBL] [Abstract][Full Text] [Related]
2. Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties. Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Milanese C; Girella A; Marini A J Pharm Sci; 2013 Nov; 102(11):4079-86. PubMed ID: 24030886 [TBL] [Abstract][Full Text] [Related]
3. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies. Parmar VK; Shah SA Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294 [TBL] [Abstract][Full Text] [Related]
4. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization. Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186 [TBL] [Abstract][Full Text] [Related]
5. Novel furosemide cocrystals and selection of high solubility drug forms. Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478 [TBL] [Abstract][Full Text] [Related]
6. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714 [TBL] [Abstract][Full Text] [Related]
7. Mechanochemical synthesis of bumetanide-4-aminobenzoic acid molecular cocrystals: a facile and green approach to drug optimization. Bruni G; Maietta M; Berbenni V; Mustarelli P; Ferrara C; Freccero M; Grande V; Maggi L; Milanese C; Girella A; Marini A J Phys Chem B; 2014 Aug; 118(31):9180-90. PubMed ID: 25062449 [TBL] [Abstract][Full Text] [Related]
8. Experimental and DFT simulation study of a novel felodipine cocrystal: Characterization, dissolving properties and thermal decomposition kinetics. Yang C; Guo W; Lin Y; Lin Q; Wang J; Wang J; Zeng Y J Pharm Biomed Anal; 2018 May; 154():198-206. PubMed ID: 29550709 [TBL] [Abstract][Full Text] [Related]
9. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide. Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368 [TBL] [Abstract][Full Text] [Related]
10. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611 [TBL] [Abstract][Full Text] [Related]
11. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
12. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion. Zhao X; Liu X; Gan L; Zhou C; Mo J Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816 [TBL] [Abstract][Full Text] [Related]
13. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches. Rahman Z; Zidan AS; Berendt RT; Khan MA Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447 [TBL] [Abstract][Full Text] [Related]
14. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization. Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510 [TBL] [Abstract][Full Text] [Related]
15. Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids. Kozak A; Marek PH; Pindelska E J Pharm Sci; 2019 Apr; 108(4):1476-1485. PubMed ID: 30414866 [TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. Douroumis D; Bouropoulos N; Fahr A J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229 [TBL] [Abstract][Full Text] [Related]
17. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage. Weuts I; Kempen D; Verreck G; Peeters J; Brewster M; Blaton N; Van den Mooter G Eur J Pharm Sci; 2005; 25(4-5):387-93. PubMed ID: 15894472 [TBL] [Abstract][Full Text] [Related]
18. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride. Heng W; Su M; Cheng H; Shen P; Liang S; Zhang L; Wei Y; Gao Y; Zhang J; Qian S Mol Pharm; 2020 Jan; 17(1):84-97. PubMed ID: 31794225 [TBL] [Abstract][Full Text] [Related]
19. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. Yadav AV; Dabke AP; Shete AS Drug Dev Ind Pharm; 2010 Sep; 36(9):1036-45. PubMed ID: 20334542 [TBL] [Abstract][Full Text] [Related]